Table 4. Hazard Ratios for polypharmacy from the Sensitivity analyses.
Unplanned admissions | Death | ED presentations | ||||
---|---|---|---|---|---|---|
HR | 95% CI | HR | 95% CI | HR | 95% CI | |
14 days | 1.21** | (1.08–1.37) | 1.11 | (.87–1.40) | .94 | (.80–1.11) |
30 days | 1.14 | (.98–1.32) | 1.02 | (.76–1.37) | .95 | (.80–1.14) |
60 days | 1.08 | (.90–1.30) | .90 | (.63–1.28) | .98 | (.79–1.21) |
90 days | 1.02 | (.80–1.29) | .83 | (.54–1.28) | .80 | (.62–1.03) |
p<0.01; 95% CI in parentheses